Evaluation of the efficacy and safety of stillen in comparison with pentoprazole in controlling the symptoms of gastro-myopic reflux in patients referred to the gastroenterology clinic of Baqiyatallah Hospital

Bagheiat-allah University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年7月16日

试验速览

暂无简介。

•Completion of informed consent form
•Diagnosis of reflux disease is confirmed by clinical and paraclinical findings.
•The patient's condition is not life-threatening.
•Do not participate in another clinical trial at the same time.
•Do not interact with medication before intervention. Like beta blocker inhibitors and herbal medicines or drugs that are harmful for treatment of reflux, such as theophylline, and others.
•Age over 18 years
•No smoking in the past
•Not pregnancy
•Failure to enter the plan for patients with psychiatric and veterinary injuries due to pulmonary symptoms

•The occurrence of severe drug-related symptoms and severe hypersensitivity to drugs that can not be controlled.
•Signs and symptoms of the patient have worsened during the study.
•Those patients who have not consumed their medication for more than a week.
•History of chemical gas and severe pulmonary disease.
•Pregnant or intending to have a pregnancy
•Presence and observation of drug interactions

发起方

Bagheiat-allah University of Medical Sciences